Manila Bulletin
MB Daily News Update
The Philippines has secured a supply agreement for 30 million doses of the Novavax COVID-19 vaccine from the Serum Institute of India.
Vaccine czar Secretary Carlito Galvez Jr. announced that the deal was finalized during a trip to India last week.
These Novavax vaccine doses, manufactured in India, are anticipated to arrive in the country during the third or fourth quarter of the year.
The Novavax vaccine has demonstrated 89.3% efficacy in a United Kingdom trial but is still awaiting approval from the Philippine Food and Drug Administration.
The Novavax vaccines are expected to form a significant portion of the Philippines' vaccine supply for the latter half of the year.
Additionally, the Philippines and India are in discussions regarding eight million doses of the vaccine developed by Indian firm Bharat Biotech.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Philippines is set to sign a supply agreement for 30 million doses of the Novavax COVID-19 vaccine, with deliveries expected in the late second quarter or early third quarter of the year.
+1
Read more →
The Philippine government and the private sector have secured a deal with Moderna for 20 million doses of its COVID-19 vaccine, making it the country's largest vaccine supply deal to date.
+2
Read more →
The Philippines is expecting 2.3 million doses of COVID-19 vaccines until early April.
Read more →
The Philippines is expecting 4.5 million more doses of the AstraZeneca COVID-19 vaccine by the end of May through the COVAX Facility.
Read more →
An additional 400,000 doses of the Sinovac COVID-19 vaccine, donated by China, arrived in the Philippines on Wednesday morning, March 24, 2021.
+2
Read more →